GO:0043330 response to exogenous dsRNA: Innate Immune Sensing, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0043330 (response to exogenous dsRNA) describes any cellular or organismal change triggered by double-stranded RNA originating outside the cell, including movement, secretion, enzyme production and gene expression.
• Exogenous dsRNA is a universal viral signature and a powerful experimental trigger for RNA interference (RNAi) and innate immune activation.
• Key sensors and effectors include OAS1/2/3, RNase L, PKR (EIF2AK2), ADAR1, MDA5 (IFIH1), RIG-I (DDX58), TLR3 and Dicer/Argonaute proteins.
• Dysregulation of the OAS-RNase L axis causes inborn errors of immunity, as shown in children with SARS-CoV-2-related multisystem inflammatory syndrome.
• Stress granules act as shock absorbers that prevent excessive innate immune responses to dsRNA, linking RNA metabolism to immune homeostasis.
• Exogenous dsRNA can drive sequence-specific RNAi in fungi and plants, enabling crop protection and functional genomics.
Description
GO:0043330, response to exogenous dsRNA, is a biological process defined as any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an exogenous double-stranded RNA stimulus. Double-stranded RNA (dsRNA) is a hallmark of viral replication and a potent trigger of innate immunity and RNA interference (RNAi). Cells have evolved specialized sensors that detect exogenous dsRNA and initiate signaling cascades leading to antiviral, inflammatory and gene-silencing responses. Understanding this process is critical for virology, immunology, RNA therapeutics and crop protection. This article synthesizes authoritative QuickGO annotation and verified PubMed literature to provide a research-grade overview of the genes, mechanisms, disease links and experimental models for GO:0043330.
response to exogenous dsRNA At A Glance
| GO ID | GO:0043330 |
|---|---|
| GO term | response to exogenous dsRNA |
| Ontology | biological_process |
| Synonym | response to exogenous double-stranded RNA; response to viral dsRNA |
| Major function | Detection and response to extracellular or exogenous double-stranded RNA, leading to antiviral, immune and gene-silencing outputs |
| Key sensors | OAS1/2/3, PKR (EIF2AK2), MDA5 (IFIH1), RIG-I (DDX58), TLR3, Dicer, Argonaute |
| Key effectors | RNase L, ADAR1, stress granule proteins, type I interferons |
| Organisms studied | Human, mouse, insect (Bombyx mori), plant (Brachypodium distachyon), fungi (Magnaporthe oryzae) |
What Is GO:0043330?
In our own words, response to exogenous dsRNA (GO:0043330) encompasses all cellular and organismal changes triggered by double-stranded RNA that originates outside the cell. These changes include altered gene expression, enzyme activation (e.g., OAS, PKR), secretion of cytokines, and in some organisms, sequence-specific RNA interference. The term captures both immediate innate immune signaling and downstream adaptive responses to foreign dsRNA.
Why Is response to exogenous dsRNA Important in Cell Biology?
Response to exogenous dsRNA is a cornerstone of antiviral defense and a key determinant of immune pathology. It is essential for clearing viral infections, but its dysregulation can cause autoinflammation, interferonopathies and severe COVID-19 outcomes. Moreover, exogenous dsRNA is the trigger for RNA interference, a revolutionary tool for gene silencing in research and therapy. In agriculture, dsRNA-induced RNAi provides a species-specific pest and pathogen control strategy. Thus, GO:0043330 bridges fundamental RNA biology, immunology and biotechnology.
• First line of antiviral defense: detects viral dsRNA and activates interferon and RNase L pathways.
• Drives sequence-specific RNAi for gene function studies and therapeutics.
• Central to autoinflammatory and interferonopathic diseases, including MIS-C.
• Modulates cancer immunotherapy responses via ADAR1 editing.
• Regulates stress granule dynamics and prevents excessive immune activation.
• Enables RNAi-based crop protection against fungal pathogens.
• Involved in insect immunity, as shown by BmToll9-2 activation in silkworm.
• Provides a model for studying autophagy and aging through RNAi.
• Links mitochondrial RNA release to type I interferon production.
• Offers targets for antiviral and anti-inflammatory drug development.
What Happens During response to exogenous dsRNA?
Sensing of exogenous dsRNA
In simple terms: Cells have sentinels that recognize foreign double-stranded RNA.
Exogenous dsRNA is detected by cytosolic sensors such as OAS1/2/3, PKR (EIF2AK2), MDA5 (IFIH1) and RIG-I (DDX58), as well as endosomal TLR3. In insects, BmToll9-2 is transcriptionally activated by exogenous dsRNA. These sensors discriminate viral dsRNA from self-RNA based on length, structure and modifications.
Activation of antiviral effectors
In simple terms: Once detected, the alarm bells ring and antiviral enzymes switch on.
OAS proteins synthesize 2'-5'-oligoadenylates, which activate RNase L to degrade viral and cellular RNA, limiting replication. PKR phosphorylates eIF2α to block translation, while MDA5 and RIG-I trigger MAVS-dependent interferon signaling. ADAR1 edits dsRNA to prevent aberrant immune activation.
RNA interference and gene silencing
In simple terms: Exogenous dsRNA can also be chopped up to specifically silence matching genes.
In many organisms, Dicer processes exogenous dsRNA into small interfering RNAs (siRNAs) that guide Argonaute to cleave complementary mRNAs, resulting in sequence-specific gene silencing. This RNAi response is used experimentally to knock down genes and in crops to target fungal pathogens.
Stress granule formation and immune modulation
In simple terms: Cells form temporary granules to buffer the stress and avoid overreacting.
Exogenous dsRNA induces stress granules that sequester dsRNA and signaling proteins, acting as shock absorbers to prevent excessive innate immune responses. This regulation is critical to avoid autoinflammation while maintaining antiviral defense.
Mitochondrial RNA and interferon amplification
In simple terms: Mitochondria can release RNA that further boosts the antiviral alarm.
Itaconate inhibits succinate dehydrogenase, leading to mitochondrial RNA release that drives type I interferon production, linking cellular metabolism to dsRNA responses. This amplification loop enhances antiviral immunity but may contribute to pathology if unchecked.
Key Genes Involved in GO:0043330 response to exogenous dsRNA
The following genes and proteins are central to the sensing, signaling and effector phases of response to exogenous dsRNA.
| Gene | Major Role | Research Relevance |
|---|---|---|
| OAS1 | Synthesizes 2'-5'-oligoadenylates to activate RNase L | Antiviral defense; biomarker in MIS-C |
| OAS2 | Same as OAS1, isoform diversity | Inborn errors of OAS-RNase L |
| OAS3 | Same as OAS1, nuclear isoform | Antiviral signaling |
| RNase L (RNASEL) | Degrades viral and cellular RNA upon activation | Host defense; mutations cause immunodeficiency |
| PKR (EIF2AK2) | Phosphorylates eIF2α to inhibit translation | Antiviral and stress response |
| ADAR1 (ADAR) | Edits dsRNA to prevent immune activation | Cancer immunotherapy resistance |
| MDA5 (IFIH1) | Cytosolic sensor of long dsRNA | Innate immunity; autoimmunity |
| RIG-I (DDX58) | Cytosolic sensor of short dsRNA | Antiviral signaling |
| TLR3 | Endosomal sensor of dsRNA | Innate immunity |
| Dicer (DICER1) | Processes dsRNA into siRNAs | RNAi pathway |
| Argonaute (AGO2) | Effector of RNAi | Gene silencing |
| BmToll9-2 | Insect Toll receptor activated by dsRNA | Insect immunity |
| Succinate dehydrogenase (SDH) | Metabolic enzyme inhibited by itaconate | mtRNA-mediated interferon |
| Stress granule proteins (e.g., G3BP1) | Form stress granules to buffer dsRNA | Immune homeostasis |
| Autophagy-related genes (ATGs) | Mediate autophagy in RNAi studies | Aging and autophagy |
| Magnaporthe oryzae genes | Fungal pathogen targeted by dsRNA | Crop protection |
How Is response to exogenous dsRNA Regulated?
Response to exogenous dsRNA is tightly regulated at multiple levels. Stress granules sequester dsRNA and signaling components to prevent excessive innate immune activation. ADAR1 editing of dsRNA suppresses MDA5 activation, and its loss leads to interferonopathy. Itaconate, via inhibition of succinate dehydrogenase, promotes mitochondrial RNA release and type I interferon production, linking metabolic state to dsRNA responses. In insects, BmToll9-2 is transcriptionally upregulated by exogenous dsRNA, indicating transcriptional feedback. These regulatory layers ensure balanced antiviral defense without autoimmunity.
response to exogenous dsRNA and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| OAS1/2/3 | MIS-C, severe COVID-19 | Knockout iPSC-derived macrophages |
| RNase L | Inborn errors of immunity | Knockout cell lines |
| ADAR1 | Cancer immunotherapy resistance | Knock-in of ADAR1 mutations |
| G3BP1 | Autoinflammation, neurodegeneration | Knockout for stress granule studies |
| SDH | Metabolic regulation of interferon | Point mutation of SDH subunits |
Inborn errors of OAS-RNase L and MIS-C
Biallelic mutations in OAS1, OAS2, RNase L or their regulators cause inborn errors of immunity characterized by impaired dsRNA degradation and severe SARS-CoV-2-related multisystem inflammatory syndrome in children (MIS-C). This highlights the non-redundant role of the OAS-RNase L axis in human antiviral defense.
ADAR1 and cancer immunotherapy resistance
Exogenous Epstein-Barr virus nuclear antigen 1 induces ADAR1-driven tumor resistance against immunotherapy by editing dsRNA and suppressing innate immune activation. Targeting ADAR1 may sensitize tumors to immune checkpoint blockade.
Stress granules and autoinflammation
Defective stress granule formation leads to excessive innate immune responses to dsRNA, contributing to autoinflammatory and neurodegenerative conditions. Modulating stress granule dynamics is a potential therapeutic strategy.
Metabolic regulation of interferon in viral infection
Itaconate-driven mitochondrial RNA release amplifies type I interferon production, which can be protective or pathogenic depending on context. This pathway is relevant to viral infections and inflammatory diseases.
From response to exogenous dsRNA-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X sense exogenous dsRNA? | Knockout cell line + dsRNA stimulation |
| Does mutation Y alter OAS-RNase L activity? | Point-mutation knock-in |
| Can ADAR1 editing be monitored? | Tagged knock-in of ADAR1 |
| Does overexpression of X enhance RNAi? | Overexpression stable line |
| Which genes regulate stress granules? | CRISPR library screening |
| How does dsRNA affect insect immunity? | BmToll9-2 knockout in silkworm cells |
How to Study the response to exogenous dsRNA Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Gene expression changes | Identify ISGs after dsRNA |
| Ribo-seq | Translation efficiency | PKR-mediated shutdown |
| Proteomics | Protein interactions | Stress granule composition |
| Imaging | Localization and dynamics | dsRNA sensing |
| CRISPR screening | Gene essentiality | Identify regulators of dsRNA response |
| qPCR | Specific gene expression | Validate OAS/RNase L |
| Western blot | Protein phosphorylation | eIF2α phosphorylation |
| RNAi knockdown | Gene silencing efficiency | Functional studies |
RNA sequencing and transcriptomics
RNA-seq after exogenous dsRNA treatment reveals global gene expression changes, including interferon-stimulated genes and RNAi components. This method identifies pathways and biomarkers of dsRNA response.
Ribo-seq and translation profiling
Ribo-seq measures translation efficiency and can detect PKR-mediated eIF2α phosphorylation effects after dsRNA exposure. It is useful for studying antiviral translational shutdown.
Proteomics and interactomics
Mass spectrometry identifies proteins interacting with dsRNA or stress granules, revealing novel sensors and effectors. It can map post-translational modifications like ADAR1 editing.
Imaging and reporter assays
Fluorescent dsRNA analogs and reporter cell lines visualize sensing and stress granule formation in live cells. High-content imaging quantifies RNAi efficiency.
How CRISPR Can Be Used to Study GO:0043330 response to exogenous dsRNA
Knockout
CRISPR knockout of OAS1, RNase L or ADAR1 in cell lines ablates dsRNA response, revealing essential genes and disease mechanisms. Knockout of stress granule proteins increases immune activation.
Point Mutation
Introducing patient-specific point mutations (e.g., in OAS1 or RNase L) via CRISPR base editing recapitulates inborn errors of immunity and tests genotype-phenotype correlations.
Knock-in
Tagged knock-in of ADAR1 or PKR allows live-cell imaging and proteomic analysis of dsRNA response components. Knock-in of reporter genes enables high-throughput screening.
Overexpression
Overexpression of MDA5, RIG-I or Dicer enhances dsRNA sensing and RNAi, useful for gain-of-function studies and bioproduction.
How EDITGENE Supports response to exogenous dsRNA Research
Researchers studying response to exogenous dsRNA-related genes often need to determine whether a candidate gene is causally involved in sensing, signaling or effector functions. EDITGENE provides comprehensive CRISPR services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for response to exogenous dsRNA research.
Frequently Asked Questions About response to exogenous dsRNA
What is GO:0043330 response to exogenous dsRNA?
GO:0043330 is a biological process describing any cellular or organismal change triggered by double-stranded RNA from outside the cell, including gene expression, enzyme production and secretion.
What genes are involved in response to exogenous dsRNA?
Key genes include OAS1/2/3, RNase L, PKR (EIF2AK2), ADAR1, MDA5 (IFIH1), RIG-I (DDX58), TLR3, Dicer and Argonaute.
How does exogenous dsRNA trigger RNA interference?
Exogenous dsRNA is processed by Dicer into siRNAs that guide Argonaute to cleave complementary mRNAs, silencing specific genes.
What diseases are linked to defects in dsRNA response?
Inborn errors of OAS-RNase L cause MIS-C, and ADAR1 dysregulation leads to cancer immunotherapy resistance.
What are stress granules in dsRNA response?
Stress granules are temporary cellular structures that sequester dsRNA and signaling proteins to prevent excessive innate immune activation.
Can exogenous dsRNA be used for crop protection?
Yes, exogenous dsRNA triggers sequence-specific RNAi in plants and fungi, offering a targeted pest control strategy.
How is response to exogenous dsRNA studied experimentally?
Common methods include RNA-seq, Ribo-seq, proteomics, imaging and CRISPR knockout screens.
What is the role of OAS-RNase L in antiviral defense?
OAS proteins synthesize 2'-5'-oligoadenylates that activate RNase L to degrade viral RNA, limiting infection.
Does exogenous dsRNA affect insect immunity?
Yes, in Bombyx mori, exogenous dsRNA transcriptionally activates BmToll9-2, an insect Toll receptor.
How does itaconate influence dsRNA response?
Itaconate inhibits succinate dehydrogenase, causing mitochondrial RNA release that drives type I interferon production.
Conclusion
GO:0043330 response to exogenous dsRNA is a fundamental biological process that integrates antiviral immunity, RNA interference and cellular stress responses. Its dysregulation underlies severe human diseases such as MIS-C and cancer immunotherapy resistance, while its manipulation offers powerful tools for gene silencing and crop protection. Continued research using CRISPR models and multi-omics will unravel new therapeutic targets and biotechnological applications.
References
- 1. Paget M et al.. 2023. Stress granules are shock absorbers that prevent excessive innate immune responses to dsRNA.. Mol Cell 83(7):1180-1196.e8 PMID: 37028415
- 2. O'Carroll SM et al.. 2024. Itaconate drives mtRNA-mediated type I interferon production through inhibition of succinate dehydrogenase.. Nat Metab 6(11):2060-2069 PMID: 39406969
- 3. Liu C et al.. 2026. Exogenous Epstein-Barr virus nuclear antigen 1 induces ADAR1-driven tumor resistance against immunotherapy.. Signal Transduct Target Ther 11(1):63 PMID: 41702895
- 4. Hannon GJ. 2002. RNA interference.. Nature 418(6894):244-51 PMID: 12110901
- 5. Zheng Y et al.. 2025. Exogenous dsRNA triggers sequence-specific RNAi and fungal stress responses to control Magnaporthe oryzae in Brachypodium distachyon.. Commun Biol 8(1):121 PMID: 39863769
- 6. Lee D et al.. 2023. Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in children.. Science 379(6632):eabo3627 PMID: 36538032
- 7. Feng Z et al.. 2025. Transcriptional activation of BmToll9-2 to exogenous dsRNA in the larvae of Bombyx mori.. J Insect Physiol 165:104860 PMID: 40701287
- 8. Pan H et al.. 2024. Mechanistic exploration of autophagy and aging by RNA interference.. Methods Cell Biol 181:213-226 PMID: 38302241
